tiprankstipranks

BioLife Solutions price target raised to $26 from $20 at TD Cowen

TD Cowen analyst Steven Ma raised the firm’s price target on BioLife Solutions to $26 from $20 and keeps a Buy rating on the shares. The firm updated its model to remove CBS (freezer) revenue given the upcoming divestiture and expect Q2 execution on conservative guide and improving backdrop.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue